Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites Nasdaq:BSGM

Press/Media: Expert Comment

PeriodJul 13 2020

Media coverage

1

Media coverage

  • TitlePhase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites Nasdaq:BSGM
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    CountryJordan
    Date7/13/20
    PersonsSlobodan Paessler, John Manning, Cheng Huang

Keywords

  • COVID-19